Elevance Health, Inc. (ELV) operating KPIs
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)
Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –
Elevance Health intersegment Operating Revenue Eliminations ($M)
Quarterly figures from Elevance Health's filings and investor materials
Latest, Q3 2026
-12,230
Period ended Sep 30, 2026
Change on a year earlier
+15.1%
-10,629 in Q3 2025
History
34 quarters
Since Q2 2018
Sources
29
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Intersegment Operating Revenue Eliminations ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2026 | Sep 30, 2026 | -12,230 | +15.1% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2026 | Jun 30, 2026 | -12,125 | +15.7% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2026 | Mar 31, 2026 | -10,965 | +15.6% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2025 | Dec 31, 2025 | -11,100 | +51.6% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2025 | Sep 30, 2025 | -10,629 | +43.4% | 8-K ER (FY2026Q3, 2026-10-21) ↗ |
| Q2 2025 | Jun 30, 2025 | -10,477 | +42.0% | 8-K ER (FY2026Q2, 2026-07-15) ↗ |
| Q1 2025 | Mar 31, 2025 | -9,483 | +31.9% | 8-K ER (FY2026Q1, 2026-04-22) ↗ |
| Q4 2024 | Dec 31, 2024 | -7,323 | +9.7% | 8-K ER (FY2025Q4, 2026-01-28) ↗ |
| Q3 2024 | Sep 30, 2024 | -7,414 | +16.1% | 8-K ER (FY2025Q3, 2025-10-21) ↗ |
| Q2 2024 | Jun 30, 2024 | -7,377 | +8.4% | 8-K ER (FY2025Q2, 2025-07-17) ↗ |
| Q1 2024 | Mar 31, 2024 | -7,188 | +3.3% | 8-K ER (FY2025Q1, 2025-04-22) ↗ |
| Q4 2023 | Dec 31, 2023 | -6,675 | +6.8% | 8-K ER (FY2024Q4, 2025-01-23) ↗ |
| Q3 2023 | Sep 30, 2023 | -6,386 | +5.5% | 8-K ER (FY2024Q3, 2024-10-17) ↗ |
| Q2 2023 | Jun 30, 2023 | -6,805 | +8.3% | 8-K ER (FY2024Q2, 2024-07-17) ↗ |
| Q1 2023 | Mar 31, 2023 | -6,957 | +15.1% | 8-K ER (FY2024Q1, 2024-04-18) ↗ |
| Q4 2022 | Dec 31, 2022 | -6,252 | -0.5% | 8-K ER (FY2023Q4, 2024-01-24) ↗ |
| Q3 2022 | Sep 30, 2022 | -6,054 | +16.6% | 8-K ER (FY2023Q3, 2023-10-18) ↗ |
| Q2 2022 | Jun 30, 2022 | -6,283 | +23.9% | 8-K ER (FY2023Q2, 2023-07-19) ↗ |
| Q1 2022 | Mar 31, 2022 | -6,045 | +23.2% | 8-K ER (FY2023Q1, 2023-04-19) ↗ |
| Q4 2021 | Dec 31, 2021 | -6,283 | +53.4% | 8-K ER (FY2022Q4, 2023-01-25) ↗ |
| Q3 2021 | Sep 30, 2021 | -5,192 | +24.9% | 8-K ER (FY2022Q3, 2022-10-19) ↗ |
| Q2 2021 | Jun 30, 2021 | -5,073 | +41.9% | 8-K ER (FY2022Q2, 2022-07-20) ↗ |
| Q1 2021 | Mar 31, 2021 | -4,908 | +36.2% | 8-K ER (FY2021Q1, 2021-04-21) ↗ |
| Q4 2020 | Dec 31, 2020 | -4,096 | +81.7% | 8-K ER (FY2021Q4, 2022-01-26) ↗ |
| Q3 2020 | Sep 30, 2020 | -4,158 | +219.1% | 8-K ER (FY2021Q3, 2021-10-20) ↗ |
| Q2 2020 | Jun 30, 2020 | -3,574 | +524.8% | 8-K ER (FY2021Q2, 2021-07-21) ↗ |
| Q1 2020 | Mar 31, 2020 | -3,603 | +655.3% | 8-K ER (FY2021Q1, 2021-04-21) ↗ |
| Q4 2019 | Dec 31, 2019 | -2,254 | +549.6% | 8-K ER (FY2020Q4, 2021-01-27) ↗ |
| Q3 2019 | Sep 30, 2019 | -1,303 | +294.8% | 8-K ER (FY2020Q3, 2020-10-28) ↗ |
| Q2 2019 | Jun 30, 2019 | -572 | 0.0% | 8-K ER (FY2020Q2, 2020-07-29) ↗ |
| Q1 2019 | Mar 31, 2019 | -477 | – | 8-K ER (FY2020Q1, 2020-04-29) ↗ |
| Q4 2018 | Dec 31, 2018 | -347 | – | 8-K ER (FY2019Q4, 2020-01-29) ↗ |
| Q3 2018 | Sep 30, 2018 | -330 | – | 8-K ER (FY2019Q3, 2019-10-23) ↗ |
| Q2 2018 | Jun 30, 2018 | -572 | – | 8-K ER (FY2019Q2, 2019-07-24) ↗ |
Cite this data
StockData. (2026). Elevance Health Intersegment Operating Revenue Eliminations ($M), quarterly Q2 2018–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg_rev_eliminations
See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.